Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regen BioPharma (RGBP) Revenue (2016 - 2025)

Historic Revenue for Regen BioPharma (RGBP) over the last 11 years, with Q3 2025 value amounting to $59366.0.

  • Regen BioPharma's Revenue changed 0.0% to $59366.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $177496.0, marking a year-over-year decrease of 2496.79%. This contributed to the annual value of $236561.0 for FY2025, which is 0.04% changed from last year.
  • Regen BioPharma's Revenue amounted to $59366.0 in Q3 2025, which was down 0.0% from $59065.0 recorded in Q2 2025.
  • Regen BioPharma's Revenue's 5-year high stood at $59714.0 during Q3 2021, with a 5-year trough of $27425.0 in Q1 2021.
  • Its 5-year average for Revenue is $57314.2, with a median of $59065.0 in 2021.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 11537.19% in 2021, then tumbled by 58.28% in 2022.
  • Regen BioPharma's Revenue (Quarter) stood at $59065.0 in 2021, then changed by 0.0% to $59065.0 in 2022, then changed by 0.0% to $59065.0 in 2023, then changed by 0.0% to $59065.0 in 2024, then increased by 0.51% to $59366.0 in 2025.
  • Its last three reported values are $59366.0 in Q3 2025, $59065.0 for Q2 2025, and $59065.0 during Q1 2025.